Results 101 to 110 of about 1,518 (190)

Malignant Peritoneal Mesothelioma as a Rare Cause of Dyspeptic Complaints and Ascites: A Diagnostic Challenge. [PDF]

GE Port J Gastroenterol, 2020
Marques de Sousa S, Pereira F, Duarte M, Marques M, Vázquez D, Marques C.   +5 more
europepmc   +1 more source

Malignant Pleural Mesothelioma: Analysis of 70 Cases in the Last Decade. [PDF]

Open Respir Arch
Garcia-Prieto F, Pardo SC, Ramírez MTR, Fernández AA.   +3 more
europepmc   +1 more source

Advances in Immunotherapy for Malignant Pleural Mesothelioma: From Emerging Strategies to Translational Insights. [PDF]

Open Respir Arch
López-Castro R, Fuentes-Martín Á, Medina Del Valle A, García Peña T, Soro García J, López González L, Cilleruelo Ramos Á.   +6 more
europepmc   +1 more source

Outcomes of multicystic peritoneal mesothelioma treatment with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. [PDF]

BJS Open, 2021
Zahid A, Clarke L, Carr N, Chandrakumaran K, Tzivanakis A, Dayal S, Mohamed F, Cecil T, Moran BJ.   +8 more
europepmc   +1 more source

Mesothelioma and Social Security Benefits in Brazil: 2019 to 2021. [PDF]

Rev Bras Med Trab
Gomes LEFE, Souza NSS.
europepmc   +1 more source

Assessing morbidity, mortality, and survival in patients with peritoneal carcinomatosis undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. [PDF]

Rev Col Bras Cir, 2023
Vallejo JSA, Queiroz FL, Lacerda Filho A, França Neto PR, Costa BXMD, Paiva RA, Garcia SLM, Silva SB.   +7 more
europepmc   +1 more source

Mesotelioma pleural secundario a radioterapia: una asociación infrecuente

Archivos de Bronconeumología, 2012
Leiro Fernández, Virginia, Fernández Villar, José Alberto, Lourido Cebreiro, Tamara   +2 more
openaire   +2 more sources

Peritoneal Mesothelioma in a Patient with Long-Standing Crohn's Disease: Cause or Coincidence? [PDF]

GE Port J Gastroenterol
Prata R, Lages Martins P, Borges VP, Botelho P, Figueiredo A, Ramos J.   +5 more
europepmc   +1 more source

Characterization of soluble PD-L1 in pleural effusions of mesothelioma patients: potential implications in the immune response and prognosis. [PDF]

J Cancer Res Clin Oncol, 2021
Carosio R, Fontana V, Mastracci L, Ferro P, Grillo F, Banelli B, Canessa PA, Dessanti P, Vigani A, Morabito A, Pfeffer U, Poggi A, Roncella S, Pistillo MP.   +13 more
europepmc   +1 more source

Outcome of patients with curative-intent treatment for primary pulmonary sarcoma: Results from an international multicenter retrospective study. [PDF]

JTCVS Open
Collaud S, Stork T, Adamkova D, Aigner C, Bravio I, Brunello A, Cerbone L, Clermidy H, De Cock L, Gasperoni S, Girard N, Mariuk-Jarema A, Lefering R, Melis E, Marquina G, Mazzeo F, Mykoliuk I, Pantaleo MA, Penel N, Schildhaus HU, Strippoli S, Vincenzi B, Watson S, Blay JY, Bauer S.   +24 more
europepmc   +1 more source